Company: SYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009279
Chunk: 4

Company: Syra Health Corp
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 4
---

    $9,071,745  
    $(5,064,955) 
    $4,013,211 

    Warrants exercised for cash 
     -  
     -  
     130,789  
     131  
     -  
     -  
     849,998  
     -  
     850,129 

    Class A common stock awarded for services 
     -  
     -  
     50,000  
     50  
     -  
     -  
     18,825  
     -  
     18,875 

    Class A common stock options issued for services 
     -  
     -  
     -  
     -  
     -  
     -  
     14,140  
     -  
     14,140 

    Net loss 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (1,447,050) 
     (1,447,050)

    Balance, March 31, 2024 
     -  
    $-  
     5,769,087  
    $5,769  
     833,334  
    $833  
    $9,954,708  
    $(6,512,005) 
    $3,449,305 
  
    Balance 
     -  
    $-  
     5,769,087  
    $5,769  
     833,334  
    $833  
    $9,954,708  
    $(6,512,005) 
    $3,449,305 

See accompanying notes to condensed unaudited financial
statements.

F-3

SYRA HEALTH CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

    2025  
    2024 

    For the Three Months Ended 

    March 31, 

    2025  
    2024 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net loss 
    $(472,265) 
    $(1